Diabetic Macular Edema

BOSTON, Massachusetts, and Seoul, South Korea — August 18, 2026 Ingenia Therapeutics announced that its shares have begun trading...

Mumbai, India and Naples, Florida, June 5, 2026 Global pharmaceutical company Lupin Limited has secured a major regulatory milestone...

STOCKHOLM, Sweden, June 3, 2026 Xbrane Biopharma AB has reached a significant regulatory milestone after the U.S. Food and...

TEL AVIV, Israel, June 4, 2026 Teva Pharmaceutical Industries Ltd. has announced the European launch of AHZANTIVE® (aflibercept), an...

Tel Aviv, Israel | May 3, 2026 Everads Therapy has announced the publication of first-in-human clinical data for its...

TARRYTOWN, N.Y., April 2, 2026 Regeneron Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...

October 14, 2025 | Zug, Switzerland — Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company advancing therapies for...